PHARMACYTE BIOTECH INC's ticker is PMCBD and the CUSIP is 71715X203. A total of 29 filers reported holding PHARMACYTE BIOTECH INC in Q4 2021. The put-call ratio across all filers is 2.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $193,383 | -75.6% | 92,087 | -66.8% | 1.31% | -73.5% |
| Q2 2023 | $792,197 | -73.6% | 276,992 | -73.1% | 4.95% | -54.1% |
| Q1 2023 | $2,998,842 | -0.9% | 1,030,530 | -0.3% | 10.77% | +30.2% |
| Q4 2022 | $3,027,071 | +22.1% | 1,033,130 | 0.0% | 8.27% | +90.0% |
| Q3 2022 | $2,480,000 | +623.0% | 1,033,130 | +574.7% | 4.35% | +681.1% |
| Q2 2022 | $343,000 | -2.6% | 153,130 | 0.0% | 0.56% | +21.9% |
| Q1 2022 | $352,000 | -8.1% | 153,130 | 0.0% | 0.46% | +26.6% |
| Q4 2021 | $383,000 | – | 153,130 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayrton Capital LLC | 92,087 | $193,383 | 1.31% |
| SABBY MANAGEMENT, LLC | 97,124 | $203,960 | 0.15% |
| K2 PRINCIPAL FUND, L.P. | 258,481 | $542,810 | 0.11% |
| EQUITEC PROPRIETARY MARKETS, LLC | 82,727 | $173,727 | 0.04% |
| CSS LLC/IL | 13,186 | $27,691 | 0.00% |
| Aspire Private Capital, LLC | 800 | $1,680 | 0.00% |
| Schonfeld Strategic Advisors LLC | 23,300 | $48,930 | 0.00% |
| OSAIC HOLDINGS, INC. | 1,971 | $4,139 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 29,307 | $61,545 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 116 | $243 | 0.00% |